Biosmith Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.80 M
- Revenue Growth -47.65%
- Profit Growth -549.39%
- Ebitda -69.06%
- Net Worth -36.33%
- Total Assets -24.17%
About Biosmith Healthcare
Biosmith Healthcare Private Limited (BHPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 July 2014 and has a history of Ten years and seven months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.80 M.
Kavita Chauhan and Sanjeev Chauhan serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24297MH2014PTC256500
- Company No.
256500
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Biosmith Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Chauhan  | Director | 05-Mar-2015 | Current |
| Kavita Chauhan | Director | 24-Jul-2014 | Current |
Financial Performance of Biosmith Healthcare.
Biosmith Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 47.65% decrease. The company also saw a substantial fall in profitability, with a 549.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 36.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biosmith Healthcare?
In 2018, Biosmith Healthcare had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.80 M
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 2019 | Idbi Bank Limited | ₹0.80 M | Open |
How Many Employees Work at Biosmith Healthcare?
Unlock and access historical data on people associated with Biosmith Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biosmith Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biosmith Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
